Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today the acceptance of an abstract for presentation at the prestigious American Society of Clinical Oncology, Genitourinary (ASCO-GU) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback